The Food and Drug Administration yesterday updated health care providers about a type of lymphoma associated with breast implants and recommendations to inform patients about the risk and report, evaluate and treat the condition. Providers, patients and manufacturers have reported 457 cases of breast implant-associated anaplastic large cell lymphoma since 2010, including nine deaths. For more information, visit www.fda.gov.

Related News Articles

Headline
The National Institutes of Health yesterday awarded grants to five new projects through its Health Care Systems Research Collaboratory, which conducts clinical…
Insights and Analysis
Plus: Specialists on call at the Mayo Clinic and health insurers are building patient profiles based on socioeconomic data.
Insights and Analysis
Older adults have complex and unique health needs, which can make their medical care more challenging.
Blog
Headline
The House last night voted 230 to 185 to approve the Standard Merger and Acquisition Reviews Through Equal Rules Act (H.R. 5645), AHA-supported legislation…
Insights and Analysis
The challenge of aligning with government payment models often hampers progress, but alternate care systems have potential to ally incentives and coordinate…